drugset / Trial / NCT00445094

A De-Escalating Strategy for Antibiotic Treatment of Pneumonia in The Medical Intensive Care Unit (0787B-092)

NCT00445094

Phase 4 Completed 120 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupOpen-labelTreatment

Summary

The primary objective of this study is a comparison between MK0787B and standard therapy.

Timeline

Start
2006-11
Primary completion
2007-01
Completion
2007-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Amikacin Small molecule
Subject Amoxicillin Other / unclassified
Subject MK0787B Unknown
Subject Vancomycin Other / unclassified

Indications